immunotherapy
The modulation of the microbiota impacts on the efficacy of the new anti-PD-1 cancer therapies. We discuss it with Giorgio Trinchieri (NIH, USA).
The gut microbiota could boost the activity of immune cells. That's according to a new study published in the journal Immunity.
Researchers have engineered bacteria that can colonize tumors and deliver immunotherapy drugs. The study was published in Nature Medicine.
The relationship between bacteria and cancer is more and more investigated. We discuss it with Laurence Zitvogel, oncologist at the Institut Gustave Roussy.
We asked Laurence Zitvogel about the advances in the field of oncological immunotherapy and the role of microbiome.
